nor-NOHA

DB02381InvestigationalSmall molecule

N-Hydroxy-nor-L-arginine (nor-NOHA) is under investigation in clinical trial NCT02009527 (Arginase Inhibition in Ischemia-reperfusion Injury).

Chemical structure of nor-NOHA
Formula / weight
C5H12N4O3 · 176.1738 g/mol (avg)
Code names
J842.499C

Resolves to

Compound
UNIIU0F1149OFRCAS189302-40-7ChEMBLCHEMBL1234777ChEBI191070PubChem446124
Structure
InChIKeyKOBHCUDVWOTEKO-VKHMYHEASA-NSMILESN[C@@H](CCNC(=N)NO)C(O)=O
Targets
P78540ARG2P05089ARG1

What you can answer from here — as of September 13, 2026

2Protein targetsEach mapped to UniProt, with action and pharmacological action
Listed above
2Clinical trialsPhase, status and sponsor resolved per trial
Sign in
2+ReferencesStructured and connected to the statements they support
Sign in

Which drugs share a target with nor-NOHA, and which of those have an active Phase 3 trial?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In